Rhythm Pharmaceuticals Setmelanotide Setmelanotide, an Melanocortin-4 Receptor (MC4R) agonists designed to treat hyperphagia and severe obesity , is approved by the US FDA to reduce excess body weight and maintain weight reduction long term in adult and pediatric patients 2 years of age and older with syndromic or monogenic obesity due to Bardet-Biedl syndrome (BBS) or genetically confirmed pro-opiomelanocortin (POMC), including proprotein convertase subtilisin/kexin type 1 (PCSK1), deficiency or leptin receptor (LEPR) deficiency
Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, et al
It sends signals to your brain that youre full, slows down how quickly your stomach empties, and helps regulate blood sugar
To examine this question, the team analyzed de-identified health records from a large commercial database